2500 Faber Place
Palo Alto , CA 94303
USA
Related Content
May 2, 2017 — CardioDx Inc. recently announced the publication of results from the multi-center, community-based PRESET ...
May 02, 2017
April 16, 2015 — CareDx Inc., a molecular diagnostics company focused on the development and commercialization of ...
April 16, 2015October 21, 2014 — CardioDx Inc., a molecular diagnostics company specializing in cardiovascular genomics, today ...
October 21, 2014February 7, 2014 — CardioDx Inc. is a molecular diagnostics company specializing in cardiovascular genomics. It ...
February 07, 2014
October 11, 2013 — CardioDx Inc. announced results of two studies indicating that Corus CAD, a blood-based gene ...
October 11, 2013
August 9, 2012 — CardioDx Inc. announced that Palmetto GBA, a national contractor that administers Medicare benefits ...
August 09, 2012
December 14, 2011 — The results of the COMPASS (Coronary Obstruction Detection by Molecular Personalized Gene Expression ...
December 14, 2011
November 18, 2009 — Results of preclinical studies with CXL-1020 demonstrate beneficial effects across the board on the ...
December 01, 2009
September 1, 2009 – CardioDx said last week it successfully completed its multicenter validation study for Corus CAD ...
August 31, 2009